Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 13;13(2):e0192271.
doi: 10.1371/journal.pone.0192271. eCollection 2018.

Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study

Philip Rauber  1 , Frank Lammert  2 , Katharina Grotemeyer  2 , Beate Appenrodt  2
Affiliations

Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study

Philip Rauber et al. PLoS One. .

Abstract

Background and aims: Thrombocytopenia occurs frequently in patients with cirrhosis. The immature platelet fraction (IPF%) is measured to differentiate the causes of thrombocytopenia. To date the relevance of thrombopoietin (TPO) in the context of cirrhosis is unknown. The aim of our study was to investigate the cause of thrombocytopenia in patients with liver cirrhosis by measuring IPF%, TPO and spleen size. In addition we examined the use of IPF% to evaluate the severity of cirrhosis and its complications.

Methods: Overall, we included 88 in-patients with cirrhosis in our study. The collected data comprises current health status, blood parameters, severity of cirrhosis evaluated by Child-Pugh score and MELD score, spleen diameter, ascites and esophageal varices. The IPF% was measured using an automatic hematology analyzer. TPO was measured with ELISA.

Results: IPF% (p = 0.003) and spleen diameter (p = 0.001) were significantly higher in patients with thrombocytopenia. There was no significant difference in TPO between patients with and without thrombocytopenia. The mean values of IPF% varied significantly (p = 0.044) in Child-Pugh stages. IPF% was significantly (p = 0.005) elevated in patients with esophageal varices. Moreover, IPF% higher than 3.85% displayed sensitivity of 76.6% and specificity of 52.4% with an area under receiver operating curve characteristics of 0.669 for the presence of esophageal varices.

Conclusion: On closer examination of the three compartments known to have an influence on platelet count splenomegaly seems to be the major cause of thrombocytopenia in patients with cirrhosis according to current knowledge. Higher IPF% in patients with thrombocytopenia indicates peripheral consumption of platelets. The relation between spleen diameter and platelet count indicates the spleen to be the major place of platelets' consumption. TPO did not differ between patients with and without thrombocytopenia. Furthermore, we cannot exclude an influence of impaired thrombopoietin synthesis on platelet counts. The association between IPF% and platelet count suggests that there is physiological regulation of platelets in patients with cirrhosis. In our study IPF% is associated with esophageal varices and the stage of cirrhosis. Further studies are needed to confirm these results.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Boxplot: IPF% and platelet count.
Fig 2
Fig 2. Boxplot: IPF% and the platelet count subgroups.
Fig 3
Fig 3. Boxplot: Spleen diameter and platelet count subgroups.
Fig 4
Fig 4. Boxplot: IPF% and Child-Pugh classification.
Fig 5
Fig 5. Boxplot: IPF% and stage of esophageal varices.
Fig 6
Fig 6. Receiver operating characteristics curve: IPF% and esophageal varices.
See this image and copyright information in PMC

References

    1. Nowatari T, Murata S, Fukunaga K, Ohkohchi N (2014) Role of platelets in chronic liver disease and acute liver injury. Hepatol Res 44: 165–172. doi: 10.1111/hepr.12205 - DOI - PubMed
    1. Bashour FN, Teran JC, Mullen KD (2000) Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol 95: 2936–2939. doi: 10.1111/j.1572-0241.2000.02325.x - DOI - PubMed
    1. Aster RH (1966) Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest 45: 645–657. doi: 10.1172/JCI105380 - DOI - PMC - PubMed
    1. Kawasaki T, Takeshita A, Souda K, Kobayashi Y, Kikuyama M, et al. (1999) Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol 94: 1918–1922. doi: 10.1111/j.1572-0241.1999.01231.x - DOI - PubMed
    1. Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, et al. (2008) Thrombocytopenia associated with chronic liver disease. J Hepatol 48: 1000–1007. doi: 10.1016/j.jhep.2008.03.009 - DOI - PubMed